Abstract:Background: Spontaneous reporting of adverse drug events (ADEs) has long been the cornerstone of pharmacovigilance. Medical institutions in China have been a major source of ADE case reports, but the proportion of reports from tertiary hospitals is low due to the serious underreporting of case reports. The same problem existed in the Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU). Objective: In order to increase the number of ADE reports and promote hospital pharmacovigilance, SAHZU's clinical pharmacists established a pharmacist-led ADE management model. The aim of this paper is to introduce this management model and explore the advantages and disadvantages of the model. Methods: Pharmacist-led ADE management model was gradually formed from 2015 to 2017 in the SAHZU. This "pharmacist-led" model is reflected not only in the fact that clinical pharmacists are the main reporters of SAHZU's ADEs but also in that they are the main groups to analyze and manage ADE and drug errors. The sources of ADEs reported by clinical pharmacists mainly include pharmacy rounds, ADE-related pharmacist consultations, centralized monitoring, ADE warning signal analysis, newly introduced drug evaluations, and drug safety research. Results: A total of 533 ADEs were reported by SAHZU to China's spontaneous reporting system (SRS) in 2017, while the data in 2012 was 177, with an increase by 201%. In 2012, the proportion of "new" and "serious" reports was 16.4%. The proportions during the period from 2015 to 2017 were 41.4%, 60.8%, and 52.2%, respectively, which were statistically significant compared with the proportion in 2012. The proportion of ADEs reported by clinical pharmacists during the period from 2014 to 2017 were 51.5%, 57.3%, 68.8%, and 90.8%, respectively, which were statistically significant compared with the proportion in 2013 (P<0.05). There was a correlation between the proportions of severe ADEs and the proportion of ADEs reported by clinical pharmacists (r=0.873, P=0.023). Four hundred eighty four ADE cases reported by clinical pharmacists to China's SRS in 2017 were mainly found in rounds of clinical pharmacists (74.17% [359/484]). Conclusion: The pharmacist-led pharmacovigilance working model significantly increased the quantity and quality of ADE reporting in SAHZU and promoted pharmacovigilance. This model is worth developing in Chinese tertiary hospitals and the following hospitals, where the physicians working there spend little time and energy on ADE reporting or the cost of physicians is high, while the clinical pharmacist team has strong professional skills.

Analysis of Benefit Game on Adverse Drug Reaction Subjects

Game Model for a New Inspection Regime of Port State Control under Different Reward and Punishment Conditions

Dynamic Game Analysis on the Drug Safety Supervision

Analysis of a Pharmacist-Led Adverse Drug Event Management Model for Pharmacovigilance in an Academic Medical Center Hospital in China

Evolution and simulation of drug safety regulations: construction of a game model for capture event

Establishment of a Rapid Identification of Adverse Drug Reaction Program in R Language Implementation Based on Monitoring Data

Research on the Strategy Development Based on Game Theory Under Medical Care System

Game-theoretic analysis of governance and corruption in China's pharmaceutical industry

Evolutionary Game Analysis of Medical Waste Disposal in China under Different Reward and Penalty Models

Analysis on the Game Theory View of the Moral Hazard in the Urban Workers' Basic Medical Insurance

Analysis of Signaling Game for Medical Credence Goods

Motivating Physicians to Report Adverse Medical Events in China: Stick or Carrot?

Optimization of Monitoring and Reporting System of Adverse Drug Reaction in Medical Organizations

Investigation on Work State of Adverse Drug Reaction Reporting in Some West Provinces

Quality Analysis of the Adverse Drug Reactions Reports from Shanghai Healthcare Professionals

A game-theoretic approach to analysis of interaction between medical institution and insurance company in commercial health insurance market

Game Analysis on the Evolution of Decision-Making of Vaccine Manufacturing Enterprises under the Government Regulation Model

Regulating the product quality of COVID-19 antigen testing reagents: A tripartite evolutionary game analysis under China's legal framework

Application of Association Rules Analysis in Mining Adverse Drug Reaction Signals

A Game Model for Medical Service Pricing Based on the Diagnosis Related Groups

Literature Analysis on Adverse Drug Reaction in China